27 At the 1-, 2-, and 3-year timepoints, they found that the GLP-1 RA cohort had a significantly lower risk of all three outcomes compared with metformin users
The lead author is Carla Nasca, PhD, a postdoctoral scholar in McEwens lab
Recently, the FDA has placed this peptide under strict evaluation regarding its use in human drug compounding, as the agency requires more large-scale data to fully confirm its long-term safety and effectiveness
E, Ive been hearing a lot about the new oral GLP-1 medications, and Id much rather take a pill than give myself a shot if I have the choice
Suggested amount: 1000mg two times a day for men and women
Individuals received a GLP-1 user flag if they had one or more Part D prescription drug event claims for a GLP-1 medication in 2023